Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestation
(MedPage Today) -- Finding poses clinical and ethical dilemma for parents and clinicians (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 9, 2024 Category: Hematology Source Type: news
Retinal hemorrhage variation in inertial versus contact head injuries - Sokoloff M, Feldman KW, Levin AV, Rockter A, Armijo-Garcia V, Musick M, Weeks K, Haney SB, Marinello M, Herman BE, Frazier TN, Carroll CL, Hymel KP.
BACKGROUND: Abusive head trauma (AHT) is frequently accompanied by dense/extensive retinal hemorrhages to the periphery with or without retinoschisis (complex retinal hemorrhages, cRH). cRH are uncommon without AHT or major trauma. OBJECTIVE: The s... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Retinal Photographs Viable for Autism Spectrum Disorder Screening
THURSDAY, Dec. 21, 2023 -- Retinal photographs may be viable for screening of autism spectrum disorder (ASD), according to a study published online Dec. 15 in JAMA Network Open.
Jae Han Kim, from the Yonsei University Health System in Seoul, South... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 21, 2023 Category: Pharmaceuticals Source Type: news
Electrifying Results: Restoring Partial Color Vision In Retinitis Pigmentosa Patients With Retinal Implants
Retinal implants have recently gained attention as a potential treatment for RP-induced color blindness. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 16, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
FDA Approves iDose TR (travoprost intracameral implant) for the Treatment of Glaucoma
ALISO VIEJO, Calif.--(BUSINESS WIRE) December 14, 2023 -- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2023 Category: Drugs & Pharmacology Source Type: news
Upstate researcher awarded $1.6 million grant to unlock the secrets of the optic chiasm that aims to advance understanding of the extracellular matrix for vision restoration
The funding will expand knowledge that could help in efforts to restore vision after retinal ganglion cells are lost; either because of disease or injury. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - December 14, 2023 Category: Universities & Medical Training Tags: News Research Source Type: news
Report: Kidney Disease Evident in These Eye Issues Report: Kidney Disease Evident in These Eye Issues
An analysis of four new studies found that retinal and choroidal thickness in the back of the eye correlates with kidney function in patients with chronic kidney disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 11, 2023 Category: Endocrinology Tags: Ophthalmology Source Type: news
Retinal OCT Can Act as Prognostic Biomarker of Kidney Injury
MONDAY, Dec. 11, 2023 -- Retinal optical coherence tomography (OCT) has potential to act as a noninvasive monitor and prognostic biomarker of kidney injury, according to a study published online Dec. 5 in Nature Communications.Tariq E. Farrah,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Investor Update - December 4, 2023 Category: Pharmaceuticals Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Media News - December 4, 2023 Category: Pharmaceuticals Source Type: news
Is A Retinal Picture Worth A Thousand Diagnoses?
Retina imaging technologies go beyond the traditional visual inspection with dilated pupils and instead offer a non-invasive and painless method to examine the retina (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 2, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Photodynamic Therapy Offers Non-Invasive Solution For Bullous Retinal Detachment
Patients suffering from bullous retinal detachment may have a new, non-invasive alternative to surgical intervention in the form of photodynamic therapy (PDT). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 30, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Augustinus Bader ’s Celeb-Approved Retinol Serum Gets Rare 25 Percent Off Discount for Cyber Week
Augustinus Bader has added yet another holy grail ingredient to his skin-saving beauty lineup. Already known for the patented TFC8 (Trigger Factor Complex), a botanical formula developed from his 30 years of stem cell research, the renowned German biomedical scientist and his eponymous skin-care…#augustinusbader #triggerfactorcomplex #retinolserum #augustinusbaderserum #violetgreycyberweek #regularly350 #violetgrey #sephoracom #bader #charlesrosier (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2023 Category: Consumer Health News Source Type: news
Oral Therapy Shown to Preserve Retina in Stargardt Disease Oral Therapy Shown to Preserve Retina in Stargardt Disease
A once-daily pill of modified vitamin A slowed the rate of retinal degeneration in patients with Stargardt disease, a rare genetic eye disease that can cause vision loss.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2023 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Retinal Capillary Perfusion Tied to Cerebral Small Vessel Disease in Black Patients
WEDNESDAY, Nov. 1, 2023 -- Lower retinal capillary perfusion is associated with cerebral small vessel disease, according to a study published online Oct. 6 in Alzheimer’s& Dementia.
Farzan Abdolahi, M.D., from University of Southern... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 1, 2023 Category: Pharmaceuticals Source Type: news
